BIOTECHNOLOGY EUROPE-NORTH AMERICA NEWS

Community

Advertising Opportunities

Biotechnology Europe Programs

Resources

Biotechnology Europe Community

BIOTECHNOLOGY EUROPE-COLORADO


30.10.2007 Pharmion and GPC Biotech AG Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 Trial

26.07.2007 Pharmion Corporation Reports Net Sales of $65.8 Million for Q2 2007

19.07.2007Pharmion Corporation to Announce Second Quarter 2007 Financial Results

26.06.2007 Pharmion Submits European Marketing Authorization Application for Satraplatin in Combination With Prednisone for the Treatment of Patients With Metastatic Hormone-Refractory Prostate Cancer Who Have Failed Prior Chemotherapy

10.05.2007 Pharmion Corporation Announces Pricing of Public Offering of Common Stock

21.02.2007 Pharmion Corporation Announces 2006 Operating Results

29.01.2007 Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration

23.01.2007 Pharmion Submits European Marketing Authorization Application for Thalidomide Pharmion(R) for Untreated Multiple Myeloma

21.11.2006 Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan






































































I back I top I

Biotechnology Europe Your Partner in Bioscience and Business

Central Internet Platform and Service Company For The Life Sciences in Europe